PPC
MRK icon

Pennington Partners & Co’s Merck MRK Stock Holding History

Pennington Partners & Co’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$355K Buy
2,745
+117
+4% +$13.7K 0.11% 99
2026
Q1 		$318K Buy
2,628
+270
+11% +$31.2K 0.11% 91
2025
Q4 		$250K Buy
+2,358
New +$221K 0.1% 82
2025
Q2 		– Sell
-2,511
Closed -$227K – 87
2025
Q1 		$227K Sell
2,511
-932
-27% -$87K 0.13% 70
2024
Q4 		$345K Buy
+3,443
New +$355K 0.17% 61

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Pennington Partners & Co's MRK Position: Q2 2026 in Review

Pennington Partners & Co increased its Merck (MRK) stake by 4.5% in Q2 2026, buying an estimated $13.7K and bringing the position to 2,745 shares worth $355K. The position accounts for 0.11% of the portfolio, ranked #99.

Pennington Partners & Co first reported a position in MRK in Q4 2024 and has held it in 5 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Pennington Partners & Co held 2,745 shares of Merck worth $355K as of Q2 2026.
  • Pennington Partners & Co bought 117 Merck shares in Q2 2026, an estimated $13.7K.
  • Merck made up 0.11% of Pennington Partners & Co's portfolio in Q2 2026, its #99 holding.
  • Pennington Partners & Co first reported a position in Merck in Q4 2024 and has held it in 5 quarters since.
  • 3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Pennington Partners & Co's 13F filing for Q2 2026, filed 14 Aug 2026.